Chladek James

BioMedtrix was founded in 1989 with the objective of designing, developing, and manufacturing state-of-the-art veterinary orthopedic implants. Our continuing mission is to provide quality in all aspects of product development, manufacturing, and customer service. Through research sponsorships and collaborations with the world's foremost surgeons, BioMedtrix continues to support the new development programs to address veterinary needs.With over 30 years of development experience in human and veterinary implants, BioMedtrix has developed proprietary processes, and has patents on several designs addressing clinical needs in the canine hip, knee and elbow. Our research and testing approaches have demonstrated improved product development cycles with product designs addressing long term clinical needs.Quality has always been a relative term amongst various medical manufacturers. However, under BioMedtrix operational policies, we maintain quality standards comparable to those used by human orthopedic manufacturers. We adhere to all ASTM specifications for implant materials and maintain standards for articulating surfaces of implants which meet or exceed those specified for human implants.In the event a client has a detailed surgical question, BioMedtrix has a panel of surgeons who can provide immediate answers. These surgeons are specialists in the veterinary orthopedic field, and cumulatively have over 200 years experience in veterinary medicine. The BioMedrix Advisory Program can be used by calling the office or through the BioMedtrix Web site.BioMedtrix is represented in over 95% of the US Veterinary Teaching Universities, selected international universities, and specialty clinics all over the world. We have over 400 clients which have been using BioMedtrix products with over 20 years clinical success. This level of support from our customers provides us the opportunity to continue product development. We strive to help you address clinical issues with innovative product solutions.

Diagnostica Stago is the exclusive provider of Diagnostica Stago hemostasis products in the United States. Diagnostica Stago offers a complete system of hemostasis instrumentation and optimized reagent kits for research as well as for routine analysis. A total quality approach plays an integral part in the corporate culture at Stago. The company is committed to a better understanding of hemostasis and thrombosis to provide clinical and research laboratories with the most advanced analyzer/reagent systems. In the United States, Diagnostica Stago has been servicing the clinical and research hemostasis laboratory community for more than 20 years with the same commitment to customers as Diagnostica Stago has maintained in Europe for the last 55 years.